Consistent with its known role as a cancer biomarker, KRT8 expression was elevated in a majority of malignant tissue samples (n = 13; mean nuance score 331.3 ± 266 standard deviation, SD) versus non-malignant tissue (n = 4; 83.8 ± 58 SD, p = 0.017). The gene discussed is KRT8; the disease is cancer.